ONCOCYTE CORP - 8-K - 20241112 - SIGNATURES
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
ONCOCYTE
CORPORATION |
| |
|
|
| Date:
November 12, 2024 |
By: |
/s/
Joshua Riggs |
| |
|
Joshua
Riggs |
| |
|
President
and Chief Executive Officer |
